These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 21883434)

  • 1. Time trends in absolute and modifiable coronary heart disease risk in patients with Type 2 diabetes in the Swedish National Diabetes Register (NDR) 2003-2008.
    Fhärm E; Cederholm J; Eliasson B; Gudbjörnsdottir S; Rolandsson O
    Diabet Med; 2012 Feb; 29(2):198-206. PubMed ID: 21883434
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of risk factors for cardiovascular diseases among Saudi diabetic patients attending primary health care service.
    Ahmed AA; Alsharief E; Alsharief A
    Diabetes Metab Syndr; 2013; 7(3):133-7. PubMed ID: 23953177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of glycemic and lipid achievements on clinical outcomes type 2 diabetic, Chinese patients with stable coronary artery disease.
    Li S; Zhang Y; Guo YL; Zhu CG; Wu NQ; Qing P; Gao Y; Sun J; Liu G; Dong Q; Li JJ
    J Diabetes Complications; 2016; 30(1):115-20. PubMed ID: 26481154
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gender differences in composite control of cardiovascular risk factors among patients with type 2 diabetes.
    Strom Williams JL; Lynch CP; Winchester R; Thomas L; Keith B; Egede LE
    Diabetes Technol Ther; 2014 Jul; 16(7):421-7. PubMed ID: 24735058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiple risk factor intervention and progression of coronary atherosclerosis in patients with type 2 diabetes mellitus.
    Kataoka Y; Shao M; Wolski K; Uno K; Puri R; Tuzcu EM; Nissen SE; Nicholls SJ
    Eur J Prev Cardiol; 2013 Apr; 20(2):209-17. PubMed ID: 22345692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management outcomes of patients with type 2 diabetes: targeting the 10-year absolute risk of coronary heart disease.
    Yong TY; Phillipov G; Phillips PJ
    Med J Aust; 2007 Jun; 186(12):622-4. PubMed ID: 17576176
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucose-lowering treatment and clinical results in 163 121 patients with type 2 diabetes: an observational study from the Swedish national diabetes register.
    Ekström N; Miftaraj M; Svensson AM; Andersson Sundell K; Cederholm J; Zethelius B; Gudbjörnsdottir S; Eliasson B
    Diabetes Obes Metab; 2012 Aug; 14(8):717-26. PubMed ID: 22364580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Considerably decreased risk of cardiovascular disease with combined reductions in HbA1c, blood pressure and blood lipids in type 2 diabetes: Report from the Swedish National Diabetes Register.
    Eeg-Olofsson K; Zethelius B; Gudbjörnsdottir S; Eliasson B; Svensson AM; Cederholm J
    Diab Vasc Dis Res; 2016 Jul; 13(4):268-77. PubMed ID: 27190080
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factor control in patients with Type 2 diabetes and coronary heart disease: findings from the Swedish National Diabetes Register (NDR).
    Gudbjörnsdottir S; Eeg-Olofsson K; Cederholm J; Zethelius B; Eliasson B; Nilsson PM;
    Diabet Med; 2009 Jan; 26(1):53-60. PubMed ID: 19125761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ABC goal achievement predicts microvascular but not macrovascular complications over 6-years in adults with type 1 diabetes: the Coronary Artery Calcification in Type 1 Diabetes Study.
    Bjornstad P; Maahs DM; Rewers M; Johnson RJ; Snell-Bergeon JK
    J Diabetes Complications; 2014; 28(6):762-6. PubMed ID: 25270733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of Patients With Diabetes Having Normal Coronary Arteries.
    Binbrek AS; Ali SM; Baslaib FO; Ali AA
    Angiology; 2015 Jul; 66(6):578-83. PubMed ID: 25092679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factor control for coronary artery disease secondary prevention in large randomized trials.
    Farkouh ME; Boden WE; Bittner V; Muratov V; Hartigan P; Ogdie M; Bertolet M; Mathewkutty S; Teo K; Maron DJ; Sethi SS; Domanski M; Frye RL; Fuster V
    J Am Coll Cardiol; 2013 Apr; 61(15):1607-15. PubMed ID: 23500281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sex-specific differences in metabolic control, cardiovascular risk, and interventions in patients with type 2 diabetes mellitus.
    Kautzky-Willer A; Kamyar MR; Gerhat D; Handisurya A; Stemer G; Hudson S; Luger A; Lemmens-Gruber R
    Gend Med; 2010 Dec; 7(6):571-83. PubMed ID: 21195357
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LDL-cholesterol versus non-HDL-to-HDL-cholesterol ratio and risk for coronary heart disease in type 2 diabetes.
    Eliasson B; Gudbjörnsdottir S; Zethelius B; Eeg-Olofsson K; Cederholm J;
    Eur J Prev Cardiol; 2014 Nov; 21(11):1420-8. PubMed ID: 23774274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New aspects of HbA1c as a risk factor for cardiovascular diseases in type 2 diabetes: an observational study from the Swedish National Diabetes Register (NDR).
    Eeg-Olofsson K; Cederholm J; Nilsson PM; Zethelius B; Svensson AM; Gudbjörnsdóttir S; Eliasson B
    J Intern Med; 2010 Nov; 268(5):471-82. PubMed ID: 20804517
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Twenty Years of Cardiovascular Complications and Risk Factors in Patients With Type 2 Diabetes: A Nationwide Swedish Cohort Study.
    Sattar N; McMurray J; Borén J; Rawshani A; Omerovic E; Berg N; Halminen J; Skoglund K; Eliasson B; Gerstein HC; McGuire DK; Bhatt D; Rawshani A
    Circulation; 2023 Jun; 147(25):1872-1886. PubMed ID: 37154040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study.
    Lind M; Bounias I; Olsson M; Gudbjörnsdottir S; Svensson AM; Rosengren A
    Lancet; 2011 Jul; 378(9786):140-6. PubMed ID: 21705065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managing patients with prediabetes and type 2 diabetes after coronary events: individual tailoring needed - a cross-sectional study.
    Munkhaugen J; Hjelmesæth J; Otterstad JE; Helseth R; Sollid ST; Gjertsen E; Gullestad L; Perk J; Moum T; Husebye E; Dammen T
    BMC Cardiovasc Disord; 2018 Aug; 18(1):160. PubMed ID: 30075751
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-traditional markers of atherosclerosis potentiate the risk of coronary heart disease in patients with type 2 diabetes and metabolic syndrome.
    Bianchi C; Penno G; Malloggi L; Barontini R; Corfini M; Giovannitti MG; Di Cianni G; Del Prato S; Miccoli R
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):31-8. PubMed ID: 17420118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inadequate achievement of ABC goals (HbA1c, blood pressure, LDL-C) among patients with type 2 diabetes in an Iranian population, 2012-2017.
    Larry M; Alizadeh S; Naderi S; Salekani B; Mansournia MA; Rabizadeh S; Esteghamati A; Nakhjavani M
    Diabetes Metab Syndr; 2020; 14(4):619-625. PubMed ID: 32422446
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.